Acumen pharmaceuticals ceo discusses novel targeted therapies for alzheimer's

New york, march 18, 2025 (globe newswire) -- today's marketplace (tmp) is proud to announce a featured interview with acumen pharmaceuticals (nasdaq: abos) ceo daniel o ' connell and jessica clark, dnp, rn, dean of the college of nursing at creighton university. the pair joined today's marketplace host elizabeth hart to discuss alzheimer's disease.

ABOS Ratings Summary

ABOS Quant Ranking